MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CSTL made $83,043,000 in revenue. -$501,000 in net income. Net profit margin of -0.60%.

Income Overview

Revenue
$83,043,000
Net Income
-$501,000
Net Profit Margin
-0.60%
EPS
-$0.02
Unit: Dollar
Revenue Breakdown
    • Dermatologic
    • Non Dermatologic

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net revenues
83,043,000 86,188,000 87,988,000 79,642,500
Cost of sales (exclusive of amortization of acquired intangible assets)
18,704,000 17,626,000 16,383,000 15,038,500
Research and development
12,960,000 12,787,000 12,588,000 12,791,000
Selling, general and administrative
55,907,000 58,065,000 58,620,000 49,230,000
Amortization of acquired intangible assets
2,276,000 1,961,000 28,325,000 3,293,500
Total operating expenses, net
89,847,000 90,439,000 115,916,000 80,353,000
Operating (loss) income
-6,804,000 -4,251,000 -27,928,000 -710,500
Interest income
2,833,000 2,944,000 3,099,000 3,184,000
Changes in fair value of equity securities
3,561,000 1,185,000 -1,425,000 277,500
Interest expense
24,000 21,000 17,000 53,000
Other expense
48,000 ---
(loss) income before income taxes
-386,000 -143,000 -26,271,000 2,698,000
Income tax expense (benefit)
115,000 -4,666,000 -423,000 -830,000
Net (loss) income
-501,000 4,523,000 -25,848,000 3,528,000
Basic (in dollars per share)
-0.02 0.16 -0.9 0.13
Basic (in shares)
29,073,000 28,914,000 28,609,000 -13,855,000
Diluted (in dollars per share)
-0.02 0.15 -0.9 0.115
Diluted (in shares)
29,073,000 29,545,000 28,609,000 -14,442,000
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$501,000 Income tax expense(benefit)$115,000 (loss) income beforeincome taxes-$386,000 Other expense$48,000 Changes in fair value ofequity securities$3,561,000 Interest income$2,833,000 Non Dermatologic$34,520,000 Dermatologic$48,523,000 Interest expense$24,000 Operating (loss) income-$6,804,000 Net revenues$83,043,000 Total operatingexpenses, net$89,847,000 Amortization of acquiredintangible assets$2,276,000 Selling, general andadministrative$55,907,000 Research and development$12,960,000 Cost of sales(exclusive of amortization...$18,704,000

CASTLE BIOSCIENCES INC (CSTL)

CASTLE BIOSCIENCES INC (CSTL)